Skip to main content
SpringerLink
Log in

Palliative Care: End-of-Life Symptoms

  • Chapter
  • First Online:
The MASCC Textbook of Cancer Supportive Care and Survivorship

Abstract

Ensuring the comfort and dignity of patients during the last hours of life is the cornerstone of palliative care. Like any aspect of supportive care and survivorship, high-quality care of the dying requires multidisciplinary expertise in the three core clinical skills: diagnosis, therapy, and prognosis. Although most cancer deaths are predictable, diagnosing that the patient is actively dying is not always easy, especially in the hospital setting. Indicators that patients are on the terminal pathway include: the patient becomes totally bedbound (typically 4–7 days before death); the patient is only able to take sips of fluid (typically indicating the last 48 h); the patient is semicomatose or only having mouth care (typically the final 24 h). The common symptoms in actively dying cancer patients include pain, restlessness (due to pain, delirium, or existential distress), retained secretions, breathlessness, and nausea. In most patients, all these problems can be controlled with just four drugs, which can all be given subcutaneously (or intravenously): an opioid, a benzodiazepine, a major tranquilizer, and an antimuscarinic agent. Occasionally, cancer patients die of a sudden catastrophic event due to hemorrhage, seizure, or choking and will require rapid sedation with a fast-acting benzodiazepine. In addition to these pharmacological maneuvers, therapy at the end of life includes stopping unnecessary tests and treatments, and clarifying preferences for life-sustaining treatment. Clarifying these preferences requires addressing the psychosocial and spiritual needs of the patient and family and incorporating their cultural values and attitudes into the plan of care. Care does not end with the death of the patient: support is needed for those who are experiencing loss, grief, and bereavement (patient, family, and staff).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    For clinicians wishing to mix drugs in syringe drivers, there is a searchable database of drug mixtures for syringe drivers at the website of Palliative Care Matters, http://www.pallcare.info (accessed 15/11/09).

References

  1. Sepulveda C, Marlin A, Yoshida T, Ullrich A. Palliative Care: the World Health Organization’s global perspective. J Pain Symptom Manage 2002;24:91–6.

    Article  PubMed  Google Scholar 

  2. Higgs R. The diagnosis of dying. J R Coll Physicians Lond 1999;33:110–2.

    PubMed  CAS  Google Scholar 

  3. Gibbins J, McCoubrie R, Alexander N, Kinzel C, Forbes K. Diagnosing dying in the acute hospital setting–are we too late? Clin Med 2009;9:116–9.

    PubMed  CAS  Google Scholar 

  4. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ 2003;326:30–4.

    Article  PubMed  Google Scholar 

  5. Quill TE, Arnold R, Back AL. Discussing treatment preferences with patients who want “everything”. Ann Intern Med 2009;151:345–9.

    PubMed  Google Scholar 

  6. Ellershaw J. Care of the dying: what a difference an LCP makes! Palliat Med 2007;21:365–8.

    Article  PubMed  Google Scholar 

  7. Bookbinder M, Blank AE, Arney E, et al. Improving end-of-life care: development and pilot-test of a clinical pathway. J Pain Symptom Manage 2005;29:529–43.

    Article  PubMed  Google Scholar 

  8. Jarabek BR, Jama AA, Cha SS, Ruegg SR, Moynihan TJ, McDonald FS. Use of a palliative care order set to improve resident comfort with symptom management in palliative care. Palliat Med 2008;22:343–9.

    Article  PubMed  CAS  Google Scholar 

  9. Glare PA, Sinclair CT. Palliative medicine review: prognostication. J Palliat Med 2008;11:84–103.

    Article  PubMed  Google Scholar 

  10. Bozcuk H, Koyuncu E, Yildiz M, et al. A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients. Int J Clin Pract 2004;58:1014–9.

    Article  PubMed  CAS  Google Scholar 

  11. Lau F, Downing GM, Lesperance M, Shaw J, Kuziemsky C. Use of palliative performance scale in end-of-life prognostication. J Palliat Med 2006;9:1066–75.

    Article  PubMed  Google Scholar 

  12. Inagaki J, Rodriguez V, Bodey GP. Proceedings: causes of death in cancer patients. Cancer 1974;33:568–73.

    Article  PubMed  CAS  Google Scholar 

  13. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990;6:7–15.

    PubMed  CAS  Google Scholar 

  14. Goncalves JF, Alvarenga M, Silva A. The last forty-eight hours of life in a Portuguese palliative care unit: does it differ from elsewhere? J Palliat Med 2003;6:895–900.

    Article  PubMed  Google Scholar 

  15. Turner K, Chye R, Aggarwal G, Philip J, Skeels A, Lickiss JN. Dignity in dying: a preliminary study of patients in the last three days of life. J Palliat Care 1996;12:7–13.

    PubMed  CAS  Google Scholar 

  16. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T. Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991;7:5–11.

    Google Scholar 

  17. Grond S, Zech D, Schug SA, Lynch J, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 1991;6:411–22.

    Article  PubMed  CAS  Google Scholar 

  18. Conill C, Verger E, Henriquez I, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997;14:328–31.

    Article  PubMed  CAS  Google Scholar 

  19. Ellershaw J, Smith C, Overill S, Walker SE, Aldridge J. Care of the dying: setting standards for symptom control in the last 48 hours of life. J Pain Symptom Manage 2001;21:12–7.

    Article  PubMed  CAS  Google Scholar 

  20. Nauck F, Klachik E, Ostgathe C. Symptom control during the last three days of life. Eur J Pall care 2001;10:81–4.

    Google Scholar 

  21. Lickiss JN. Approaching cancer pain relief. Eur J Pain 2001;5 Suppl A:5–14.

    Google Scholar 

  22. Ellershaw JE, Kinder C, Aldridge J, Allison M, Smith JC. Care of the dying: is pain control compromised or enhanced by continuation of the fentanyl transdermal patch in the dying phase? J Pain Symptom Manage 2002;24:398–403.

    Article  PubMed  CAS  Google Scholar 

  23. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19:2542–54.

    PubMed  CAS  Google Scholar 

  24. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008;358:2332–43.

    Article  PubMed  CAS  Google Scholar 

  25. Mercadante S. Pathophysiology and treatment of opioid-related myoclonus in cancer patients. Pain 1998;74:5–9.

    Article  PubMed  CAS  Google Scholar 

  26. Daeninck PJ, Bruera E. Opioid use in cancer pain. Is a more liberal approach enhancing toxicity? Acta Anaesthesiol Scand 1999;43:924–38.

    Article  PubMed  CAS  Google Scholar 

  27. Eisele JH, Jr., Grigsby EJ, Dea G. Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report. Pain 1992;49:231–2.

    Article  PubMed  Google Scholar 

  28. Portenoy RK, Sibirceva U, Smout R, et al. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage 2006;32:532–40.

    Article  PubMed  Google Scholar 

  29. Sulmasy DP, Pellegrino ED. The rule of double effect: clearing up the double talk. Arch Intern Med 1999;159:545–50.

    Article  PubMed  CAS  Google Scholar 

  30. Mercadante S, Intravaia G, Villari P, Ferrera P, David F, Casuccio A. Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage 2009;37:771–9.

    Article  PubMed  Google Scholar 

  31. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004;291:88–93.

    Article  PubMed  CAS  Google Scholar 

  32. Breitbart W, Alici Y. Agitation and delirium at the end of life: “we couldn’t manage him”. JAMA 2008;300:2898–910; E1.

    Google Scholar 

  33. Macleod AD. The management of delirum in hospice practice. Eur J Palliat Care 1997;4:116–20.

    Google Scholar 

  34. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994;9:341–5.

    Article  PubMed  CAS  Google Scholar 

  35. Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231–7.

    PubMed  CAS  Google Scholar 

  36. Rietjens JA, van Zuylen L, van Veluw H, van der Wijk L, van der Heide A, van der Rijt CC. Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation. J Pain Symptom Manage 2008;36:228–34.

    Article  PubMed  Google Scholar 

  37. Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol 2008;26:2396–404.

    Article  PubMed  Google Scholar 

  38. Cuervo Pinna MA, Mota Vargas R, Redondo Moralo MJ, Correas MA. Pharmacologic intervention for cancer-related dyspnea. J Clin Oncol 2008;26:4225; author reply 6.

    Google Scholar 

  39. Currow DC, Agar M, Smith J, Abernethy AP. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliat Med 2009;23:309–16.

    Article  PubMed  CAS  Google Scholar 

  40. Hughes A, Wilcock A, Corcoran R, Lucas V, King A. Audit of three antimuscarinic drugs for managing retained secretions. Palliat Med 2000;14:221–2.

    Article  PubMed  CAS  Google Scholar 

  41. Hugel H, Ellershaw J, Gambles M. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide. J Palliat Med 2006;9:279–84.

    Article  PubMed  Google Scholar 

  42. Dreifuss FE, Rosman NP, Cloyd JC, et al. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med 1998;338:1869–75.

    Article  PubMed  CAS  Google Scholar 

  43. Dean A, Tuffin P. Fibrinolytic inhibitors for cancer-associated bleeding problems. J Pain Symptom Manage 1997;13:20–4.

    Article  PubMed  CAS  Google Scholar 

  44. Nauck F, Alt-Epping B. Crises in palliative care–a comprehensive approach. Lancet Oncol 2008;9:1086–91.

    Article  PubMed  Google Scholar 

  45. Currow D, Clark K. Emergencies in palliative and supportive care. Oxford: Oxford University; 2006:50–2.

    Google Scholar 

  46. O’Neill WM. Subcutaneous infusions–a medical last rite. Palliat Med 1994;8:91–3.

    Article  PubMed  Google Scholar 

  47. Grassby PF, Hutchings L. Drug combinations in syringe drivers: the compatibility and stability of diamorphine with cyclizine and haloperidol. Palliat Med 1997;11:217–24.

    Article  PubMed  CAS  Google Scholar 

  48. Coyle N. Suffering in the first person. In: Ferrell BR, ed. Suffering. Boston: Jones and Bartlett; 1996:44–54.

    Google Scholar 

  49. Ferrell BR, Coyle N, eds. The nature of suffering and the goals of nursing. Oxford: Oxford University; 2008.

    Google Scholar 

  50. Cassem NH. The dying patient. In: Cassem NH, Stern TA, Rosenbaum JF, Jellinek MS, eds. Massachusetts General Hospital handbook of General Hospital Psychiatry. 4th ed. St Louis: Mosby-Year Book; 1997:605–36.

    Google Scholar 

  51. Speck P, ed. Teamwork in palliative care – fulfilling or frustrating. Oxford: Oxford University; 2006.

    Google Scholar 

  52. Ingham J, Coyle N. Teamwork in end-of-life care. In: Clark D, Hockley J, Ahmedzai S, eds. A nurse physician perspective on introducing physicians to palliative care concepts. New Themes in Palliative Care, Buckingham: Open University; 1997:255–74.

    Google Scholar 

  53. Coyle N. Introduction to palliative nursing. In: Ferrell BR, Coyle N, eds. Textbook of palliative nursing, 2nd ed. Oxford: Oxford University; 2006:7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Memorial Sloan Kettering Cancer Center, Pain & Palliative Care Service, 1275 York Avenue, New York, NY, 10065, USA

    Paul Glare

Authors
  1. Paul Glare
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tanya Nikolova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nessa Coyle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Glare .

Editor information

Editors and Affiliations

  1. Clinical Professor, Cancer Coucil Australia, University of Sydney Medical School, Surry Hills, 2010, New South Wales, Australia

    Ian N. Olver

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Society for Imaging Informatics in Medicine

About this chapter

Cite this chapter

Glare, P., Nikolova, T., Coyle, N. (2010). Palliative Care: End-of-Life Symptoms. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1225-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1225-1_4

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-1224-4

  • Online ISBN: 978-1-4419-1225-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation